Prime

Vaccine manufacture plan in new phase on World Bank nod

Kenya BioVax Institute CEO Dr Michael Lusiola (left) showing an architectural plan model to the World Bank Vice President for Human Development Mamta Murthi (centre) and State Department for Medical Services Permanent Secretary Harry Mutai when they toured Kenya BioVax Institute in Embakasi, Nairobi on February 7,2024.

Photo credit: File | Nation Media Group

By  Linet Owoko

Correspondent

Nation Media Group

Kenya is set to begin the second phase of its vaccine manufacturing programme after the World Bank endorsed the completion of Phase One at the BioVax Institute's facility in Embakasi, Nairobi.

Phase One focused on enabling works – the essential groundwork required before installing specialised vaccine production machinery.

Related

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.

Get it First!

Stay up to date on the editors' picks of the week.

Latest

  1. PRIME Investors lose Sh93bn in Kenya startup failures

  2. PRIME How family feuds led to bankruptcy of Kamotho children

  3. Kenya could become a regional hub for African social commerce

  4. PRIME South Africa’s Vodacom Group fights to keep majority stake in Safaricom

In the headlines

View All